Monoclonal Antibody Reduced Proteinuria in IgA Nephropathy

(MedPage Today) — At the American Society of Nephrology (ASN) Kidney Week meeting, an interim analysis of a phase III trial of sibeprenlimab in immunoglobulin A (IgA) nephropathy showed a nearly 50% reduction in proteinuria at 9 months, with favorable…

Source link : https://www.medpagetoday.com/meetingcoverage/kidneyweekvideopearls/118651

Author :

Publish date : 2025-11-21 19:13:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Monoclonal Antibody Reduced Proteinuria in IgA Nephropathy

Cardiologists Still Have Little Idea Who Is Going to Have a Heart Attack

Telehealth-Based Cancer Trial; AI-Based Cancer Biomarkers; Myeloma Survival Landmark

Related Posts

‘Most Compelling’ Data Yet for Metastasis-Directed Therapy in Prostate Cancer

FDA Wants Drug Pulled From Market, Citing Liver Risk. Company Says No

AI Tool Rapidly Flags Patients Ineligible for Thrombolysis

Stroke Trial Tips Scale Further to Favor Intra-Arterial Lytic After EVT

WHO Announces Restart of Preventive Cholera Vaccinations After Nearly 4-Year Halt

GLP-1 ‘Agonorexia’; Psychotic Disorders Rising in Young People; Pink Noise Pitfalls

‘Most Compelling’ Data Yet for Metastasis-Directed Therapy in Prostate Cancer

FDA Wants Drug Pulled From Market, Citing Liver Risk. Company Says No

AI Tool Rapidly Flags Patients Ineligible for Thrombolysis

Stroke Trial Tips Scale Further to Favor Intra-Arterial Lytic After EVT

WHO Announces Restart of Preventive Cholera Vaccinations After Nearly 4-Year Halt

GLP-1 ‘Agonorexia’; Psychotic Disorders Rising in Young People; Pink Noise Pitfalls

These Aren’t the Ob/Gyn Droids We’re Looking For

Keto Diet Shows Antidepressant Effect in Drug-Resistant Depression

Categories

Archives